West Paces Advisors Inc. Immuno Precise Antibodies Ltd. Transaction History
West Paces Advisors Inc.
- $410 Billion
- Q4 2024
A detailed history of West Paces Advisors Inc. transactions in Immuno Precise Antibodies Ltd. stock. As of the latest transaction made, West Paces Advisors Inc. holds 1,665 shares of IPA stock, worth $649. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,665
Previous 1,665
-0.0%
Holding current value
$649
Previous $1.06 Million
35.62%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding IPA
# of Institutions
20Shares Held
1.91MCall Options Held
0Put Options Held
0-
Ingalls & Snyder LLC New York, NY1.56MShares$608,9190.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny78.2KShares$30,4980.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$16,0680.0% of portfolio
-
Northern Trust Corp Chicago, IL41.1KShares$16,0310.0% of portfolio
-
Bank Of Montreal Toronto, A635.3KShares$13,7690.0% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $9.69M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...